BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9250306)

  • 1. Cervical cancer screening in Japan. A case-control study.
    Sato S; Makino H; Yajima A; Fukao A
    Acta Cytol; 1997; 41(4):1103-6. PubMed ID: 9250306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.
    Makino H; Sato S; Yajima A; Komatsu S; Fukao A
    Tohoku J Exp Med; 1995 Mar; 175(3):171-8. PubMed ID: 7792786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].
    Makino H; Sato S; Yajima A; Fukao A
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1226-32. PubMed ID: 1919184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection against squamous cell carcinoma and cervical adenocarcinoma afforded by cervical cytology screening: a cross-sectional study.
    Vale DB; Braganca JF; Morais SS; Zeferino LC
    Int J Gynecol Cancer; 2014 Feb; 24(2):321-8. PubMed ID: 24407579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytological screening history of patients with early invasive cervical cancer.
    Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
    Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of the effectiveness of cervical cancer screening in Osaka, Japan.
    Sobue T; Suzuki T; Hashimoto S; Yokoi N; Fujimoto I
    Jpn J Cancer Res; 1988 Dec; 79(12):1269-75. PubMed ID: 3148596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and adenocarcinoma of the cervix.
    Sasieni P; Castanon A; Cuzick J
    Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cytologic screening on the detection of cervical carcinoma.
    Yajima A; Mori T; Sato S; Wakisaka T; Suzuki M
    Obstet Gynecol; 1982 May; 59(5):565-8. PubMed ID: 7070726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of uterine cancer detected by mass screening].
    Igarashi T; Konno R; Sato S; Yajima A
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1519-26. PubMed ID: 9725043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.
    Silfverdal L; Kemetli L; Andrae B; Sparén P; Ryd W; Dillner J; Strander B; Törnberg S
    Am J Obstet Gynecol; 2009 Aug; 201(2):188.e1-7. PubMed ID: 19560117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the appropriate frequency of the cervical cancer screening (author's transl)].
    Hando T; Kodama S; Obata N; Goto A; Takeuchi S; Aoki S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1205-8. PubMed ID: 7276648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
    Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
    Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening interval and risk of invasive squamous cell cervical cancer.
    Miller MG; Sung HY; Sawaya GF; Kearney KA; Kinney W; Hiatt RA
    Obstet Gynecol; 2003 Jan; 101(1):29-37. PubMed ID: 12517642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening: patients understanding in major hospitals in Malaysia.
    Othman NH; Devi BC; Halimah Y
    Asian Pac J Cancer Prev; 2009; 10(4):569-74. PubMed ID: 19827871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of cervical screening: a population-based case-control study.
    van der Graaf Y; Zielhuis GA; Peer PG; Vooijs PG
    J Clin Epidemiol; 1988; 41(1):21-6. PubMed ID: 3335869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.